Atlas Trials

Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer

Clinical trial NCT00527982 · TERMINATED

Trial details

NCT number
NCT00527982
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck CancerLung Cancer
Start date
2005-09-01
Primary completion
2008-09-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.